Travere Therapeutics, Inc. Annual Amortization of Intangible Assets in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Travere Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2013 to 2023.
  • Travere Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $10.8M, a 0.88% decline year-over-year.
  • Travere Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $39M, a 45.7% increase year-over-year.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $36.3M, a 95% increase from 2022.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $18.6M, a 68.4% increase from 2021.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $11M, a 50.8% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $36.3M +$17.7M +95% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $18.6M +$7.56M +68.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $11M -$11.4M -50.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $22.4M +$2.73M +13.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $19.7M +$1.68M +9.31% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $18M +$697K +4.02% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $17.3M +$1.34M +8.37% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $16M +$2.76M +20.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $13.2M +$7.95M +151% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
2014 $5.28M +$4.95M +1529% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $324K Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.